Core Viewpoint - NASB Financial, Inc. reported a net income of $6.9 million for the quarter ended June 30, 2025, reflecting an increase from the previous quarter and a slight increase year-over-year [1][2]. Financial Performance - For the quarter ended June 30, 2025, net income was $6.9 million or $0.96 per share, compared to $5.8 million or $0.80 per share for the quarter ended March 31, 2025, and $6.8 million or $0.92 per share for the quarter ended June 30, 2024 [1]. - For the nine months ended June 30, 2025, net income totaled $20.7 million or $2.86 per share, down from $22.1 million or $2.99 per share for the same period in 2024 [2]. Financial Highlights - Net interest income for the quarter was $19.957 million, compared to $19.560 million in the previous quarter and $19.802 million in the same quarter last year [4]. - Provision for credit losses was $370 thousand for the quarter, up from $135 thousand in the previous quarter and a recovery of $9 thousand in the same quarter last year [4]. - Non-interest income increased to $2.4 million from $518 thousand in the previous quarter and $1.174 million in the same quarter last year [4]. - Non-interest expense was $12.833 million, slightly up from $12.240 million in the previous quarter and $12.399 million in the same quarter last year [4]. - Total assets as of June 30, 2025, were $2.939 billion, a decrease from $3.034 billion in the previous quarter and an increase from $2.787 billion year-over-year [4]. - Total loans held for investments and mortgage-backed securities were $2.162 billion, consistent with the previous quarter and slightly up from $2.161 billion year-over-year [4]. - Customer and brokered deposit accounts totaled $1.835 billion, down from $1.918 billion in the previous quarter and up from $1.700 billion year-over-year [4]. - Stockholders' equity increased to $423.572 million from $420.814 million in the previous quarter and $407.079 million year-over-year [4]. Financial Ratios - Book value per share was $58.70, up from $58.18 in the previous quarter and $55.06 year-over-year [4]. - Earnings per share for the quarter was $0.96, compared to $0.80 in the previous quarter and $0.92 year-over-year [4]. - Return on assets (annualized) was 0.92%, up from 0.78% in the previous quarter and down from 0.96% year-over-year [4]. - Return on equity (annualized) was 6.54%, up from 5.57% in the previous quarter and down from 6.70% year-over-year [4].

Financial Performance - The company will review Q2 financial results [1] - The company will introduce new metrics [1] Company Updates - The company will provide an update on its capital plan [1] - The company will discuss $MSTR, $STRK, $STRF, $STRD, and $STRC [1] Investor Relations - The company will host a live Q&A session [1]

Core Insights - Universal Music Group N.V. (UMG) reported strong financial results for Q2 and H1 2025, driven by growth in Recorded Music and Music Publishing segments [4][10][14] Financial Performance - Q2 2025 revenue reached €2,980 million, a 1.6% increase year-over-year, or 4.5% in constant currency, with growth in Recorded Music and Music Publishing [6][8] - H1 2025 revenue was €5,881 million, up 6.4% year-over-year, or 6.9% in constant currency, attributed to improvements in both segments [10][14] - Adjusted EBITDA for Q2 2025 was €676 million, a 4.2% increase year-over-year, or 7.3% in constant currency, with an Adjusted EBITDA margin of 22.7% [6][9] - H1 2025 Adjusted EBITDA was €1,336 million, up 7.7% year-over-year, or 8.5% in constant currency, maintaining an Adjusted EBITDA margin of 22.7% [12][14] Segment Performance Recorded Music - Q2 2025 Recorded Music revenue was €2,224 million, a 1.1% increase year-over-year, or 3.9% in constant currency, with subscription revenue growing 5.3% and streaming revenue increasing 4.4% [20][21] - H1 2025 Recorded Music revenue totaled €4,464 million, up 6.5% year-over-year, or 7.0% in constant currency [21] - Recorded Music EBITDA for H1 2025 was €1,092 million, improving 13.9% year-over-year, with an EBITDA margin of 24.5% [23] Music Publishing - Q2 2025 Music Publishing revenue was €570 million, an 11.5% increase year-over-year, or 14.5% in constant currency, driven by digital revenue growth [25][26] - H1 2025 Music Publishing revenue reached €1,125 million, up 11.6% year-over-year, or 12.1% in constant currency [27] - Music Publishing EBITDA for H1 2025 was €252 million, a 10.0% increase year-over-year, with an EBITDA margin of 22.4% [28] Merchandising and Other - Q2 2025 Merchandising and Other revenue declined to €192 million, down 15.4% year-over-year, or 12.7% in constant currency, due to lower direct-to-consumer sales [30] - H1 2025 revenue for Merchandising and Other was €305 million, a 10.6% decrease year-over-year, attributed to the same factors [31] Profitability Metrics - Net profit attributable to equity holders for H1 2025 was €1,432 million, compared to €914 million in H1 2024, resulting in an EPS of €0.78 [14] - Adjusted net profit for H1 2025 was €882 million, leading to an Adjusted EPS of €0.48, up from €0.44 in H1 2024 [14] Cash Flow and Dividends - Net cash provided by operating activities before income tax paid increased to €488 million in H1 2025, compared to €436 million in H1 2024 [15] - An interim dividend of €440 million, or €0.24 per share, was declared for H1 2025 [17] Debt Position - Net debt at the end of H1 2025 was €2,734 million, an increase from €2,098 million at the end of 2024, primarily used for investing activities and dividends [18]

Core Insights - Scholastic Corp. reported strong second-quarter results, with adjusted earnings of 87 cents per share, surpassing the analyst consensus estimate of 85 cents [1] - Quarterly revenue reached $508.3 million, exceeding the Street estimate of $494.58 million [1] Financial Performance - The company achieved solid financial results in fiscal 2025, with strong Adjusted EBITDA aligning with original guidance [2] - Continued strength in Children's Book Publishing and Distribution, along with disciplined cost management, helped mitigate macroeconomic pressures on school spending affecting the Education division [3] Future Outlook - Scholastic anticipates "significant growth" in fiscal 2026 Adjusted EBITDA, projecting it to be between $160 million and $170 million, driven by core business strength and cost savings, despite ongoing challenges in school spending [4] - Revenue growth is expected to be between 2% to 4% in fiscal 2026 [4] Stock Performance - Following the earnings report, Scholastic stock rose by 12.39%, reaching $24.22 in extended trading [4]

Core Viewpoint - Environmental Tectonics Corporation (ETC) reported a 39% increase in operating income for the first fiscal quarter of 2026, driven by increased sales in Aircrew Training Systems (ATS) and reduced operating expenses compared to the previous year [2][7]. Financial Performance - **Net Income**: Net income for the first fiscal quarter of 2026 was $1.3 million, or $0.07 diluted earnings per share, a slight decrease from $1.4 million or $0.08 diluted earnings per share in the same quarter of 2025 [3][21]. - **Net Sales**: Net sales increased to $17.6 million, up $4.1 million or 30.5% from $13.5 million in the prior year, primarily due to a 74.9% increase in ATS sales [4][21]. - **Gross Profit**: Gross profit was $4.7 million, representing 26.5% of net sales, compared to $4.5 million or 33.6% of net sales in the previous year [5][21]. - **Operating Expenses**: Operating expenses decreased by $0.5 million, or 16.0%, to $2.5 million, mainly due to lower research and development costs [6][21]. - **Operating Income**: Operating income rose to $2.2 million, an increase of $0.6 million or 39.4% compared to the previous year [7][21]. Expense Analysis - **Interest Expense**: Interest expense increased to $0.6 million, a rise of $0.4 million or 385.3% from the previous year, due to increased borrowing [9][21]. - **Income Tax Provision**: The income tax provision was $0.4 million, up from $0.0 million in the prior year, reflecting a non-cash tax expense related to the utilization of Net Operating Loss carryforwards [10][21]. Cash Flow Overview - **Operating Activities**: Cash flows used in operating activities were $2.7 million, a decrease of $5.6 million compared to $2.9 million provided in the previous year [11][21]. - **Investing Activities**: Cash used for investing activities remained consistent at $0.1 million for both quarters [12][21]. - **Financing Activities**: Financing activities provided $1.0 million in cash during the first fiscal quarter of 2026, contrasting with $3.1 million used for repayments in the previous year [12][21]. Business Segments - ETC operates primarily in two segments: Aerospace Solutions and Commercial/Industrial Systems, focusing on products and services for government and civil aviation organizations [14][16].

Core Viewpoint - Asante Gold Corporation reported significant operational progress and financial results for Q1 2026, with expectations for continued growth and production increases in the coming years [3][5][14]. Financial Results - Revenue for Q1 2026 was $141.98 million, a 24% increase from $114.31 million in Q1 2025, driven by higher gold prices despite a lower volume of gold sold [4][5]. - Total comprehensive loss for the quarter was $(20.04) million, compared to $(16.04) million in the same period last year [4]. - Adjusted EBITDA rose to $30.66 million from $13.03 million year-over-year, reflecting the impact of high gold prices [6]. Operational Results - Gold equivalent production was 51,912 ounces, down from 53,379 ounces in the same quarter of the previous year, attributed to lower feed grades at the Bibiani mine [7][11]. - The average gold price realized per ounce was $2,946, compared to $2,133 in the same period last year [5]. - All-in sustaining costs (AISC) increased by 58% to $2,971 per ounce, primarily due to increased stripping costs and lower grade ore [8][12]. Bibiani Mine Performance - Total material mined at Bibiani increased by 291.4% to 11,970 kt, while ore mined decreased by 4.8% to 558 kt [9][10]. - The strip ratio at Bibiani was 20.5:1, significantly higher than 4.2:1 in the previous year, reflecting the company's strategy to reduce waste stripping backlog [9][10]. - Revenue from Bibiani was $46.67 million, up from $41.31 million year-over-year, with an average gold price realized of $2,794 per ounce [9]. Chirano Mine Performance - Revenue for the Chirano mine was $95.31 million, an increase from $73.00 million in the same quarter of 2024 [15]. - Gold equivalent production was 34,671 ounces, slightly up from 34,196 ounces year-over-year, despite a decrease in ore grade processed [19]. - AISC for Chirano increased to $2,587 per ounce from $1,951 per ounce, driven by higher sustaining capital expenditures [20]. Future Outlook - The company plans to produce between 155,000 and 175,000 gold ounces at both Bibiani and Chirano for the year ending January 31, 2026, with significant production increases expected in the latter part of the fiscal year [14][21]. - The commissioning of the sulphide treatment plant is anticipated to enhance gold recovery and is expected to be fully operational by Q3 2026 [13][14].

Market Overview - U.S. stocks showed mixed performance, with the Dow Jones index slightly increasing by 0.05% to 42,238.88, while the NASDAQ fell by 0.74% to 19,033.46 and the S&P 500 decreased by 0.24% to 5,898.22 [1] - Consumer staples shares rose by 1%, while information technology stocks declined by 1.5% [1] Company Performance - Dell Technologies Inc. saw its shares drop over 3% after reporting mixed financial results for Q1, with revenue of $23.38 billion exceeding estimates of $23.14 billion, but adjusted earnings of $1.55 per share fell short of the expected $1.69 per share [2] - Universal Corporation's shares increased by 11% to $65.96 following positive quarterly results [8] - Ulta Beauty, Inc. shares surged 11% to $470.18 after reporting better-than-expected Q1 financial results and raising guidance [8] - BioLineRx Ltd. shares rose by 34% to $5.20 due to promising results from a pancreatic cancer trial [8] - Summit Therapeutics Inc. shares dropped by 30% to $18.33 after announcing topline results from its Phase 3 trial [8] - Newsmax, Inc. shares fell by 19% to $18.08 following the announcement of a resale of up to 121 million shares [8] - CollPlant Biotechnologies Ltd. shares decreased by 33% to $3.0450 after announcing a $3.6 million registered direct offering [8] Economic Indicators - The University of Michigan consumer sentiment was revised higher to 52.2 in May from a preliminary reading of 50.8 [10] - The Chicago PMI declined to 40.5 in May, down from 44.6 in the previous month [10]

Core Viewpoint - Eltek Ltd. reported a revenue increase of approximately 8% year-over-year for Q1 2025, driven by strong demand for its printed circuit board products, despite facing challenges with gross margins due to rising labor costs and new production equipment integration [2][4]. Financial Performance - Revenues for Q1 2025 were $12.8 million, up from $11.8 million in Q1 2024, and 18.5% higher than Q4 2024 [2][5]. - Net income for Q1 2025 was $1.0 million, or $0.15 per fully diluted share, compared to $1.7 million, or $0.27 per fully diluted share in Q1 2024 [6][9]. - Gross profit for Q1 2025 was $2.2 million, representing a gross margin of 17%, down from $3.3 million and 28% in Q1 2024 [5][6]. - Operating profit for Q1 2025 was $0.7 million, compared to $1.7 million in Q1 2024 [5][9]. - EBITDA for Q1 2025 was $1.2 million, or 9% of revenues, down from $2.1 million, or 18% of revenues in Q1 2024 [7]. Cash Position - As of March 31, 2025, cash and short-term bank deposits totaled $15.7 million, with no outstanding debt [6]. Future Outlook - The company plans to complete its accelerated investment program by mid-2026 and is preparing for the integration of new production lines [3]. - Eltek anticipates that its efforts to expand commercial sales will yield positive results throughout 2025 and beyond [4]. Company Overview - Eltek Ltd. specializes in the manufacture of technologically advanced printed circuit boards (PCBs) and serves high-end markets, including defense, aerospace, and medical industries [11]. - The company is ITAR compliant and holds AS-9100 and NADCAP Electronics certifications, indicating its commitment to quality and regulatory standards [11].

Core Insights - SOS Limited reported significant growth in commodity trading revenue, which increased to $214.3 million in FY 2024, accounting for 92.6% of total revenue, up from 74.0% in FY 2023 [3][4][8] - The company experienced a decline in cryptocurrency mining revenue, dropping to $9.3 million from $18.9 million in FY 2023, primarily due to a temporary shutdown of its Texas mining facility for upgrades [4][8] - Operating expenses rose to $28.6 million in FY 2024, a 50.6% increase from $18.99 million in FY 2023, driven by higher general and administrative costs and selling expenses [10][12][13] Revenue Breakdown - Commodity trading revenue reached $214.3 million, representing 92.6% of total revenue in FY 2024, compared to $68.4 million (74.0%) in FY 2023 [3][4] - Cryptocurrency mining revenue fell to $9.3 million (4.0%) in FY 2024 from $18.9 million (20.4%) in FY 2023 [4][5] - Hosting service revenue increased to $6.5 million (2.8%) from $2.4 million (2.6%) in FY 2023 [3][5] Cost and Expenses - Costs of revenue surged from $78.2 million in FY 2023 to $224.4 million in FY 2024, an increase of $146.2 million [9] - Selling expenses increased significantly to $2.8 million in FY 2024, a 300% rise from $0.7 million in FY 2023 [11] - General and administrative expenses rose by 64% to $18.1 million, largely due to increased depreciation of mining rigs [12] Financial Performance - The company reported an operating loss of $21.6 million in FY 2024, compared to a loss of $4.8 million in FY 2023 [13] - Basic GAAP EPS was $(0.0299) for FY 2024, slightly worse than $(0.0269) in FY 2023 [13] - Cash and cash equivalents decreased to approximately $239.5 million as of December 31, 2024, down from $279.2 million in the previous year [15] Cash Flow Analysis - Net cash used in operating activities was $(63.6) million for FY 2024, a significant decline from $9.7 million generated in FY 2023 [19] - The net cash generated from financing activities increased to $24.6 million in FY 2024, up from $17.6 million in FY 2023 [20] - The company incurred a cash outflow of $69.3 million from changes in other receivables in FY 2024, compared to $25.2 million in FY 2023 [25]

Core Insights - Microbix Biosystems Inc. reported Q2 and H1 fiscal 2025 results, showing a mixed performance with improved gross margins but a decline in overall revenues compared to the previous year [1][2][6]. Financial Performance - Q2 revenue was $5.3 million, a 5% decrease from $5.6 million in Q2 2024, with antigen revenues increasing by 5% to $4.3 million, while QAPs revenues fell by 38% to $864,320 due to delays in assay-development programs [3][10]. - H1 revenue totaled $11.4 million, a 19% decrease from $14.0 million in H1 2024, influenced by the absence of $4.1 million in Kinlytic licensing payments; excluding this, revenues increased by 14% [6][8]. - Gross margin for Q2 improved to 60% from 53% in the previous year, driven by better manufacturing efficiencies and pricing strategies [4][10]. - H1 gross margin was 61%, slightly down from 65% in H1 2024, but improved by 10% when excluding the impact of Kinlytic licensing revenues [7]. Operating Expenses and Income - Operating expenses in Q2 increased by 21% compared to Q2 2024, primarily due to higher investments in R&D and sales and marketing [4][10]. - Q2 net income was $20,664, a significant drop from $377,730 in Q2 2024, while H1 net income was $877,627 compared to $2.8 million in H1 2024, largely due to the absence of Kinlytic licensing fees [5][8]. Cash Position and Liquidity - Cash and equivalents at the end of Q2 stood at $14.5 million, an increase of $1.5 million from the previous quarter, despite debt repayments and share repurchases [5][10]. - The current ratio improved to 9.68, and the debt to equity ratio decreased to 0.27, indicating enhanced financial strength [9][10]. Business Outlook - Management expressed a cautious outlook for the second half of fiscal 2025, particularly for the Antigens business, due to reduced sales into China [2][11].